2Borodin AM, Koroleva EB, Xvatova SV. PCR-based diagnostics of community-acquired pneumonia of mycoplasmal and Chlamydia etiologies. Klin Lab Diag.,2005,42( 1 ) :51-52.
3Munteanu I, Husar I, Didilescu C, et al. Considerations about the efficiency of treatment regimens with fixed Rifampicin-Isoniazid combinations in pulmonary tuberculosis. Pneumologia, 2006,53 ( 1 ) :23-25.
4Roth VR, Garrett DO, Laserson KF, et al. A multicenter evaluation of tuberculin skin test positivity and conversion among health care workers in Brazilian hospitals. Int J Tuberc Lung Dis, 2005,9 (12) : 1335-1342.
5Johnson SM, Bruckner F, Collins D. Distribution of Mycoplasma pneumoniae and Mycoplasma salivarium in the synovial fluid of arthritis patients. J Clin Mierobio1,2007,45 (3) :953-957.
6Blium NM, Ariel' BM, Bellendir EN, et al. Specific and nonspecific bronchial and regional lymph nodal lesions as a manifestation of synergism in the lymph epithelial system in pulmonary tuberculosis. Prebl Tuberk Bolezn Legk ,2008,12( 1 ) :8-12.
7Borzenko AS, Gagarina SG, Samo Ylova IV, et al. Primary drug resistance in Myeobacterium tuberculosis among patients with pulmonary tuberculosis and its impact on permanent disability in the Volgograd region. Probl Tuberk Bolezn Legk, 2007,12 ( 1 ) : 28- 30.
